Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 12, Number 1, January 2006

Vaccines for Pandemic Influenza

Catherine J. Luke* and Kanta Subbarao*
*National Institutes of Health, Bethesda, Maryland, USA

 
 
Figure.
  Back to article
 

Figure. A) The 8-plasmid reverse genetics system to generate recombinant, live, attenuated pandemic influenza vaccines. Six plasmids encoding the internal genes of the attenuated donor virus are mixed with 2 plasmids encoding the circulating avian virus hemagglutinin (HA) and neuraminidase (NA) genes (which may or may not have been modified to remove virulence motifs). Qualified cells are transfected with the plasmids, and the attenuated reassortant virus is isolated. B). Generation of live, attenuated pandemic influenza vaccine viruses with the 6 internal genes from the attenuated donor virus bearing attenuating mutations (*) and the HA and NA genes from the circulating avian virus by classic reassortment. The 6-2 reassortants generated by this method are selected in the presence of antiserum specific for HA and NA of the attenuated donor virus.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed December 20, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention